AI-generated summary
In a mouse model of oral carcinogenesis induced by 4-NQO, the authors report that red laser photobiomodulation at 660 nm did not change the size, thickness, classification, or grade of leukoplakia or carcinomas compared with untreated mice. The authors suggest PBM may be safe for patients with these lesions, but the study was done in mice.
- Participants
- 41
- Who or what was studied
- 41 female C57Bl/6 mice with 4-NQO-induced oral leukoplakia and squamous cell carcinoma
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice, and the safety suggestion for patients is not directly tested by these findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 30 mW, 100 mW
- Total energy
- 1.5 J, 9 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Control group, Wavelength, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.